Comparison of Movement Pattern Training and Manual Therapy for Prearthritic Hip Disorders: a Pilot Randomized Clinical Trial
Comparison of Movement Pattern Training and Manual Therapy for Prearthritic Hip Disorders: a Pilot Randomized Clinical Trial
Significance: Intra-articular, prearthritic hip disorders (PAHD) result in substantial dysfunction in young adults and are proposed precursors to hip osteoarthritis (OA). Our long term goal is to develop effective treatment strategies for people with PAHD that will improve function, decrease pain and prevent or delay the onset of OA. The purpose of this study is to compare movement pattern training (MoveTrain) and manual therapy (ManTher) in their effect on post-treatment, patient-reported outcomes and targeted impairments thought to contribute to PAHD.
This pilot study will collect sufficient data to power a future study that will determine the efficacy of MoveTrain compared to ManTher for people with PAHD. Participants with PAHD will be randomized into one of two treatment groups, MoveTrain or ManTher. The Hip disability and Osteoarthritis Outcome Score (HOOS) will be the primary outcome measure. A measure of hip adduction motion during functional tasks and quantitative sensory assessment (pain pressure threshold and temporal summation) will be the secondary measures used to assess the effect of respective treatment on the impairments thought to contribute to PAHD, thus addressing the mechanisms of pain. Upon completion of this study, we will be positioned to implement a large RCT (randomized clinical trial) to definitively assess the efficacy of MoveTrain and ManTher to improve PAHD.
Specific Aims: To obtain preliminary estimates of effect sizes for planning the future definitive randomized clinical trial,
Aim 1 (Function): we will compare post-treatment improvements in hip-specific, patient-reported outcomes among the two treatment groups. After treatment completion:
Aim 2 (Mechanism): we will compare pre- and post-treatment measures in lower extremity movement patterns during functional tasks (MoveTrain) and quantitative sensory testing (ManTher). After treatment completion:
Aim 3 (Prognosis): we will determine the association among personal factors at baseline (demographic and psychosocial) and treatment prognosis (improvement in HOOS).
Impact: Our line of research will improve our understanding of each proposed treatment and its effect on patient function and each treatment's targeted impairment. This improved understanding will lead to the development of treatment strategies that will ultimately result in comparative effectiveness studies of surgical and non-surgical treatment.
Inclusion Criteria:
Age 18-40 years
Have frequent hip joint symptoms, defined as pain, aching or stiffness within the hip joint for at least 3 months during the past 12 months
Hip joint pain confirmed upon physical exam
Report pain >= 3/10
Reports functional limitation as demonstrated by modified Harris Hip Score <90
Has protective sensation in the feet
Exclusion Criteria:
Previous hip surgery, fracture, pelvic/hip infection or cancer
Pain due to high impact trauma
Inflammatory disease, e.g. rheumatoid arthritis, gout
Acute pain in another joint that limits functional activities
Perthes disease or slipped capital femoral epiphysis
Hip pain referred from another source, e.g. lumbar spine
Neurological involvement affecting balance or coordination
Use of assistive gait device for more than 50% of time walking
Pain, numbness or tingling in the lower extremity
Pregnancy or given birth in previous 12 weeks
Unwilling to refrain from taking NSAIDs 1-2 days prior to testing session
Unable to attend regular physical therapy sessions
Unable to complete 12 month follow up session